• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Become a TBVI partner
        • Access to services
        • Conferences, meetings and workshops
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • MTBVAC in Newborns
        • MTBVAC in newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Advisory Committee

    Home / About us / Organisation / Advisory Committee
    • Dr Nick Drager (Chair)
      Dr Nick Drager (Chair)Executive Director
    • Dr Carol Holm-Hansen
      Dr Carol Holm-HansenSenior scientist Norwegian Institute of Public Health Oslo, Norway
      • Prof. Willem Hanekom
        Prof. Willem HanekomDirector of the Africa Health Research Institute (AHRI) in KwaZulu-Natal, South Africa.
        • Dr Gerd Zettlmeissl
          Dr Gerd ZettlmeisslFormer CEO Valneva SE (formerly Intercell AG) Vienna, Austria
          • Ingrid Murillo Jelsbak
            Ingrid Murillo JelsbakClinical Research Director at Biofabri, Porriño, Spain
            • Dr Gerald Voss
              Dr Gerald VossOperational Office Scientific Director
            • Olga Rué Clarós
              Olga Rué ClarósCEO Archivel Farma S.L. Badalona (Barcelona), Spain.
              • (chair) Prof Mark Hatherill
                (chair) Prof Mark HatherillDirector, South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town
                • Frank Cobelens, MD MSc PhD
                  Frank Cobelens, MD MSc PhDProfessor of Global Health at the Amsterdam University Medical Centers, loc. AMC, UvA, & Amsterdam Inst. for Global health & Devel. (AIGHD)
                  • Ole F. Olesen, M.Sc, HD, Ph.D, FRCP(Edin)
                    Ole F. Olesen, M.Sc, HD, Ph.D, FRCP(Edin)Executive Director of the European Vaccine Initiative (EVI)
                    • Ann M. Ginsberg, M.D., Ph.D.
                      Ann M. Ginsberg, M.D., Ph.D.Deputy Director, TB Vaccines, the Bill & Melinda Gates Foundation
                      Menu
                      • Home
                      • About us
                      • What we do
                      • How we work
                      • For researchers and vaccine developers
                      • For funders
                      • Pipeline of vaccines
                      • News
                      TuBerculosis Vaccine Initiative (TBVI)

                      Runderweg 6
                      8219 PK Lelystad
                      The Netherlands
                      Email: info@tbvi.eu
                      Phone: +31 320 277 550

                      © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

                      Start typing and press Enter to search

                      Cookies

                      This website uses cookies that help the website function

                      OK No